Gene · 347
NIH grants1,371
NIH grants whose papers are about the gene, through NIH's grant-paper links.
161 to 180 of 1,371
Download this page as JSON| Grant | Title | APOD papers | Newest fiscal year |
|---|---|---|---|
| R01HL161386 | Role of Adiposomes in Diabetes-Associated Endothelial Dysfunction and Restorative Effects of Exercise and Metabolic Surgery | 1 | 2025 |
| R01HL162299 | Novel roles of RNA modifications in the pathogenesis of pulmonary vascular remodeling and PAH | 1 | 2025 |
| R01HL164014 | Negative regulators of endothelial regeneration in aging lungs and ARDS | 1 | 2025 |
| R01HL170604 | Multimodal omics approach to identify health to cardiometabolic disease transitions | 1 | 2025 |
| R01MH125516 | Assessing Genomic, Regulatory and Transcriptional Variation at Single Nuclei Resolution in the Brains of Individuals with Autism Spectrum Disorder | 1 | 2025 |
| R01NS028840 | Mitogenic Activities in Neurofibromatosis | 1 | 2025 |
| R01NS088137 | Targeting TGFb/IFNy-IRF8 Signaling to Modulate Monocytes and their Crosstalk with Microglia and Astrocytes to Treat Multiple Sclerosis | 1 | 2025 |
| R01NS095441 | Dietary Sodium, Neurovascular Dysfunction and Cerebrovascular Risk | 1 | 2025 |
| R01NS106907 | Mesenchymal Stem Cell Derived Extracellular Vesicles for Traumatic Brain Injury | 1 | 2025 |
| R01NS122782 | Microglial-Neurovascular Dynamics and Regulation of Neurovascular Structure and Function | 1 | 2025 |
| R01NS127187 | Identification of TDP-43 Modifiers Through Single-Cell Transcriptional and Epigenomic Dissection of ALS and FTLD-MND | 1 | 2025 |
| R21DK138390 | Catheter-associated molecular patterns and arteriovenous fistula failure | 1 | 2025 |
| R24HD000836 | Laboratory of Developmental Biology | 1 | 2025 |
| R25CA056452 | Cancer Prevention Education: Student Research Experiences | 1 | 2025 |
| R25MH071584 | Integrated Mentored Patient-Oriented Research Training (IMPORT) in Psychiatry | 1 | 2025 |
| R25MH101078 | Translational Research Activities in Neuropsychiatry (TRAIN) - Renewal - 1 | 1 | 2025 |
| R35CA197568 | Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery | 1 | 2025 |
| R35GM131707 | Control of cell proliferation and differentiation by growth pathways | 1 | 2025 |
| R35HL150754 | Identifying new strategies for prevention of cardiovascular complications of diabetes | 1 | 2025 |
| R35HL155460 | Harnessing Glycoproteomics and Glycomics to Understand Cardiac Biology and Disease | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/347/grants?page=9